| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.24 | Vertex Pharmaceuticals Incorporated: Vertex Presents Positive Long-Term Data On CASGEVY (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update | 649 | Business Wire | - Data from long-term follow-up of patients in clinical trials further demonstrate durability of the transformative benefits of CASGEVY -
Safety profile consistent with busulfan conditioning and... ► Artikel lesen | |
| 08.12.24 | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis | 606 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Preliminary analyses from the EPCORECLL-1 trial demonstrates overall response rate (ORR) of 61 percent and complete response (CR) rate of 39 percent in heavily pretreated... ► Artikel lesen | |
| 08.12.24 | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | 848 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and 80 percent 21-month progression-free survival (PFS) in patients with... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TESLA | 3.804 |
| NVIDIA | 3.210 |
| RHEINMETALL | 2.047 |
| RENK GROUP | 1.785 |
| THYSSENKRUPP | 1.685 |
| STEYR MOTORS | 1.618 |
| BYD | 1.581 |
| BAYER | 1.564 |
| NEL | 1.459 |
| DEUTZ | 1.446 |
| TUI | 1.406 |
| VOLKSWAGEN | 1.234 |
| EVOTEC | 1.152 |
| NOVO NORDISK | 1.132 |
| MERCEDES-BENZ | 1.013 |
| XIAOMI | 947 |
| AMAZON | 938 |
| PUMA | 891 |
| PORSCHE AG | 876 |
| BASF | 862 |
| COMMERZBANK | 786 |
| DEUTSCHE BANK | 784 |
| NORDEX | 772 |
| AIXTRON SE | 732 |
| VONOVIA | 640 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
